z-logo
open-access-imgOpen Access
Response to comment on: Löndahl et al. Hyperbaric Oxygen Therapy Facilitates Healing of Chronic Foot Ulcers in Patients With Diabetes. Diabetes Care 2010;33:998–1003
Author(s) -
Magnus Löndahl,
Per Katzman,
Anders Nilsson,
Christer Hammarlund
Publication year - 2011
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc11-0403
Subject(s) - medicine , diabetes mellitus , hyperbaric oxygen , diabetic foot , foot (prosody) , hyperbaric oxygenation , intensive care medicine , surgery , endocrinology , linguistics , philosophy
There is increasing evidence for the use of hyperbaric oxygen therapy (HBOT) in selected patients with chronic diabetic foot ulcers (1). However, several issues still need to be answered, including health economics.In an editorial commenting on our study, Lipsky and Berendt (2) reported costs between $50,000 and $200,000 for a full course of HBOT treatment in the U.S. Van der Staal et al. (3) report significantly lower cost/reimbursement in the Netherlands at €6,916 for 40 HBOT sessions. Our Hyperbaric Centre in the southern part of Sweden is reimbursed €9,462 for 40 HBOT sessions, whereas at another Swedish center, …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom